Address
Forward Ventures Services LLC
9393 Towne Centre Drive
Suite 200
San Diego, CA 92121
United States
Phone
Website
Recent investment activity
KANDO id: 28814
Corporate information
Official name
Forward Ventures Services LLC
Also known as
Forward Ventures
Registration country
Funds managed
| Fund | Type | Vintage | Currency | Committed capital |
|---|---|---|---|---|
| Forward V |
Funding rounds
Investment activity status
Not investing
Selected investments
Displaying 1 - 25 of 40| Company | Profile | Country | Date | Funding | ||
|---|---|---|---|---|---|---|
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_no-logo.png?itok=AH4pbDYM){kind=icon}
|
Affinium Pharmaceuticals Ltd | Developing a novel class of antibiotics. | N/A | |||
|
|
Ambit Biosciences Inc | A biopharmaceutical company engaged in the discovery and development of small molecule kinase inhibitors for the treatment of cancer. | Series D | |||
|
|
Asteres Inc | Commercialized a system to store and deliver finished prescriptions to consumers in retail pharmacy. | Series C | |||
|
|
Avalon Pharmaceuticals Inc | Biopharmaceutical company focused on the discovery and development of small molecule therapeutics for the treatment of cancer. | N/A | |||
|
|
Cabrellis Pharmaceuticals Corp | Development of important therapies for the treatment of cancer | Series A | |||
|
|
Cellective Therapeutics Inc | N/A | ||||
|
|
Conforma Therapeutics Corp | Novel drugs company for the selective treatment of cancer. | N/A | |||
|
|
Converge Medical Inc | N/A | ||||
|
|
Dynavax Technologies Corp | N/A | ||||
|
|
EPIX Pharmaceuticals Inc | N/A | ||||
|
|
Essentialis Inc | Developing a novel therapy for the treatment of dyslipidemia. | Series B | |||
|
|
Hypnion Inc | N/A | ||||
|
|
Kemia Inc | N/A | ||||
|
|
LigoCyte Pharmaceuticals Inc | N/A | ||||
|
|
Micromet Inc | Designs and develops innovative antibody based drugs for the treatment of cancer, autoimmune and inflammatory diseases | N/A | |||
|
|
MMR Information Systems Inc (Favrille Inc) | N/A | ||||
|
|
Morphotek Inc | Biotechnology company focused on the generation of proprietary organisms for product discovery and development. | N/A | |||
|
|
Nereus Pharmaceuticals Inc | Series E | ||||
|
|
Nereus Pharmaceuticals Inc | Series D | ||||
|
|
Nereus Pharmaceuticals Inc | N/A | ||||
|
|
Nereus Pharmaceuticals Inc | Series A | ||||
|
|
NovaCardia Inc | Cardiovascular pharmaceutical company focused on the development and commercialization of novel clinical stage drug candidates. | N/A | |||
|
|
NovoStent Corp | N/A | ||||
|
|
Pharmion Corp | Initially, Pharmion concentrated its efforts on licensing products in the areas of hematology, oncology and supportive care. | N/A | |||
|
|
Proprius Pharmaceuticals Inc | N/A |
Team
| Employee | Position | |||
|---|---|---|---|---|
| Standish M Fleming (founder) | [email protected] | |||
| Ivor Royston (founder) | [email protected] | |||
| Kristen Bailey | [email protected] | |||
| Stuart J M Collinson | [email protected] |
Former team members
| Employee | Company | Position | ||
|---|---|---|---|---|
| Julia Ronlov | Gen-Probe Inc | Associate Director
Business Development |